AQP1 and asthma: Recently, the co-receptor, HVEM (herpesvirus entry mediator), also known as tumor necrosis factor receptor superfamily 14 (TNFRSF14), has emerged as a potential novel biomarker for asthma, thanks to its reported association with disease severity in asthma patients (13).